Bridging the Gap
We offer business development services for the biopharmaceutical and medical device industries. Based in Santa Clara, California, we operate throughout the United States as well as Japan and South Korea, and through an affiliate in China.
Conceived in 2004 with the premise that Asia will play an increasingly important role in the global healthcare industry, we help companies out-license and in-license biopharmaceutical and medical device assets and technologies – from preclinical to marketed.
After an initial focus of licensing late-stage innovative biopharmaceuticals from the US to South Korea, MedCI expanded its geographical reach to include Japan and China in 2012 and 2013, respectively. Since 2017, MedCI has been increasingly involved with helping Asia-based biopharmaceutical companies with business development activities in the US. In 2021, we expanded our expertise to include medical devices.
Led by a highly experienced and cross-functional team with deep industry networks, MedCI garners a holistic understanding of the technology and marketing impact to provide diverse perspectives and solutions to complex issues and, ultimately, meaningful results to our clients. Our approach is firmly anchored by an intimate understanding of the cultural nuances and business etiquettes of international business that smooths discussions and fosters goodwill.
In this industry, there are no off-the-shelf or one-size-fits-all solutions. We bring a boutique philosophy to each transaction, giving a small number of clients the high level of attention they need to build valuable and long-term relationships with business partners.